Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock proteins (HSPs) are molecular chaperones that, when released from stressed or dying cells, form complexes with antigenic peptides. These complexes are recognized and internalized by dendritic cells primarily via surface receptors such as CD91 and SREC-I. The process is known as heat shock protein receptor-mediated uptake and is pivotal for the activation and maturation of dendritic cells, polarizing immune responses towards Th1 phenotypes, stimulating cytokine secretion, and initiating adaptive immunity. This mechanism is being explored in vaccine development and cancer immunotherapy, due to its ability to efficiently present antigens and elicit robust cellular immune responses.
Facilitation of antigen uptake and cross-presentation, resulting in T cell activation Promotion of dendritic cell maturation and cytokine/chemokine production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein receptor (dendritic cell).